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Uncalibrated semi-invasive continous monitoring of cardiac index (CI) has recently gained increasing interest. The aim of the
present study was to compare the accuracy of CI determination based on arterial waveform analysis with transpulmonary
thermodilution. Fifty patients scheduled for elective coronary surgery were studied after induction of anaesthesia and before and
after cardiopulmonary bypass (CPB), respectively. Each patient was monitored with a central venous line, the PiCCO system, and
theFloTrac/Vigileo-system.MeasurementsincludedCIderivedbytranspulmonarythermodilutionanduncalibratedsemi-invasive
pulse contour analysis. Percentage changes of CI were calculated. There was a moderate, but signiﬁcant correlation between pulse
contour CI and thermodilution CI both before (r2 = 0.72, P<0.0001) and after (r2 = 0.62, P<0.0001) CPB, with a percentage
error of 31% and 25%, respectively. Changes in pulse contour CI showed a signiﬁcant correlation with changes in thermodilution
CI both before (r2 = 0.52, P<0.0001) and after (r2 = 0.67, P<0.0001) CPB. Our ﬁndings demonstrated that uncalibrated semi-
invasivemonitoringsystemwasabletoreliablymeasureCIcomparedwithtranspulmonarythermodilutioninpatientsundergoing
elective coronary surgery. Furthermore, the semi-invasive monitoring device was able to track haemodynamic changes and trends.
1.Introduction
E s t i m a t i o no fh a e m o d y n a m i cv a r i a b l e ss u c ha sl e f tv e n t r i c u -
lar stroke volume and cardiac index in high-risk patients is a
prerequisite for performing individual goal-directed therapy.
Perioperative haemodynamic optimization and individual
tailored therapy have been shown to improve patients’
outcome by reducing morbidity and the length of stay on the
intensive care unit [1–3]. In clinical practice, determination
of cardiac index in the past was mostly related to invasive
procedures such as right heart catheterization or femoral
access, baring method-related complications and limitations
[4–6]. In this context, less-invasive techniques based on
arterialwaveformanalysishavegainedincreasinginterest[7–
9]. An example for a semi-invasive device for estimation
of CI by pulse contour analysis is the FloTrac/Vigileo-
system (Edwards Lifesciences LLC, Irvine, CA, USA), which
was introduced in 2005 and since then underwent several
software upgrades. The underlying method is described in
detailelsewhere[10,11].Thissystemrequiresonlyanarterial
line connected to a special transducer (FloTrac) and has
been investigated in several studies under various clinical
conditions, but its precision to reﬂect CI is still under debate
[12–14].
The aim of the present study was to investigate the preci-
sion of CI determination based on arterial waveform analysis2 The Scientiﬁc World Journal
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Figure 1: Study design. T1: data collection (CIWave,C I TPTD) after induction of anaesthesia and passive leg raising (PLR 1) until
cardiopulmonary bypass; T2: data collection (CIWave,C I TPTD) after cardiopulmonary bypass until the end of surgery and passive leg raising
(PLR 2).
by a third-generation device (CIWave) with transpulmonary
thermodilution (CITPTD) before and after cardiopulmonary
bypass (CPB). Furthermore, we studied the ability of the
semi-invasivetechniquefortrackinghaemodynamicchanges
and trends.
2.MaterialsandMethods
After approval from our institutional ethics committee
(Christian Albrecht University Kiel, Schwanenweg 20, D-
24105 Kiel), written informed consent for participation in
the study was obtained from all patients.
Fifty patients undergoing elective coronary artery bypass
grafting (CABG) were studied after induction of general
anaesthesia until discharge to the intensive care unit. Exclu-
sion criteria were patients <18 years of age, a left ventricular
ejection fraction ≤0.5, emergency procedures, and patients
with haemodynamic instability requiring continuous phar-
macologic support. Patients with intracardiac shunts, severe
aortic, tricuspid or mitral stenosis or insuﬃciency and
mechanical circulatory support were also excluded.
2.1. Instrumentation and Protocol. All patients were pre-
medicated with midazolam 0.1mg/kg orally 30min before
induction of anaesthesia. Routine monitoring was estab-
lished including peripheral oxygen saturation (SpO2)a n d
heart rate (HR) (S/5 monitor, GE Healthcare, Helsinki,
Finland). Subsequently patients received a peripheral venous
access and a radial arterial line. A FloTrac/Vigileo-system
was connected to the arterial line, followed by adjust-
ment of the transducer and input of required individual
demographic data according to the manufacturer’s instruc-
tions (Software version 1.07, “third generation”). Variables
were automatically indexed to body surface area. After
induction of anaesthesia with sufentanil (0.5μg/kg) and
propofol (1.5mg/kg), orotracheal intubation was facilitated
with rocuronium (0.6mg/kg). Anaesthesia was maintained
with sufentanil (1μg/kg/h), and propofol (3mg/kg/h) and
patients were ventilated with an oxygen/air mixture using a
tidal volume of 8mL/kg ideal body weight and positive end-
expiratory pressure was set at 5cm H2O. After placement of
a central venous catheter in the right internal jugular vein,
a transpulmonary thermodilution catheter (Pulsion Medical
Systems; Munich, Germany) was introduced in the femoral
artery. The thermodilution catheter was connected to the
PiCCO2 monitor (Software version 1.3.0.8).
2.2. Data Collection. After induction of anaesthesia, CITPTD
and CIWave were recorded every 10 minutes both before
and after CPB. Stable haemodynamic conditions and an
undamped arterial signal were prerequisites for the measure-
ments. CITPTD was determined by injecting 15mL ice cold
saline (≤8◦C) through the central venous line at least three
times randomly assigned to the respiratory cycle. In case of
ad i ﬀerence of ≥15%, the value obtained was discarded and
the measurement repeated. Simultaneously, measurement of
CIWave was performed by plotting 5 numerical values over a
period of three minutes and determining the mean value.
Systolic, diastolic, and mean arterial pressures as well as
CVP were also recorded every 10 minutes. After induction of
anaesthesia,apassivelegraisingmanoeuvre(PLR1)wasper-
formed, and haemodynamic variables including CI (CITPTD,
CIWave) and stroke volume index (SVI) were recorded before,
duringandafterPLR.Subsequently,measurementsofCITPTD
and CIWave were carried out every 10 minutes until the
beginning of CPB (T1), which diﬀered from patient to
patient yielding diﬀerent numbers of measurements in this
time period. Measurements of CITPTD and CIWave were
restarted 15 minutes after weaning from CPB and were
obtained up to the end of the surgical intervention (T2),
again yielding a diﬀerent number of measurement pairs
in individual patients. Immediately before discharge to the
intensive care unit, a second PLR manoeuvre (PLR 2) was
performed. Study design is displayed in Figure 1.
2.3. Statistical Analysis. All data are given as mean ± SD.
Statistical comparisons were performed using commercially
available statistics software (GraphPad Prism 5, GraphPadThe Scientiﬁc World Journal 3
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Figure 2: Correlation and Bland-Altman analysis of cardiac index measured by transpulmonary thermodilution (CITPTD) and cardiac index
measured by uncalibrated semi-invasive pulse contour analysis (CIWave) before (T1) and after (T2) cardiopulmonary bypass.
Table 1: Haemodynamic variables before (T1) and after (T2)
cardiopulmonary bypass.
Variables Pre-CPB Post-CPB
T1 (n = 245) T2 (n = 223) P
HR (min−1)5 7 ± 38 0 ± 4 P<0.05#
MAP (mmHg) 76 ± 57 3 ± 10 P<0.05#
CVP (mmHg) 10 ± 29 ± 4 P = 0.11
SVRI (dynes·s/cm5/m2) 2370 ± 62 1966 ± 121 P<0.05#
CITPTD (L/min/m2)2 .4 ±0.62 .8 ±0.6 P<0.05#
CIWave (L/min/m2)2 .4 ±0.52 .8 ±0.6 P<0.05#
CPB:cardiopulmonarybypass;HR:heartrate;MAP:meanarterialpressure;
CVP: central venous pressure; SVRI: systemic vascular resistance index;
CITPTD: cardiac index by transpulmonary thermodilution; CIWave: cardiac
index by semi-invasive pulse contour analysis; values are given as mean ±
SD. #P<0.05 (versus T1).
Software Inc., San Diego, CA, USA, and MedCalc for
Windows, version 11.6.1.0, MedCalc Software, Mariakerke,
Belgium). To demonstrate the relationship between sample
size and the width of the conﬁdence interval of the estimated
variable, we calculated the width of the 95% conﬁdence
interval of the limits of agreement as recommended by Bland
and Altman (as ±1.96

(3/n) · s,w h e r es is the standard
deviation of the bias). For our sample size of 50 patients, we
calculate a width of the 95% conﬁdence interval of the limits
ofagreementof0.51timestheSD(ofbias),whichisgenerally
thought to be an acceptable narrow 95% conﬁdence interval.
To describe the agreement between CITPTD and CIWave,
Bland-Altman plots for repeated measures were calculated
for each time period (T1-T2) before and after CPB. Per-
centage error was calculated as described by Critchley and
colleagues, using the limits of agreement (2SD) of the bias
divided by the mean CI values from CITPTD and CIWave.
Bland-Altman plots were also performed for haemodynamic
trends (ΔCITPTD, ΔCIWave) before and after CPB. Changes of
CITPTD < 15% were excluded from analysis as recommended
by Critchley and colleagues [15]. Unpaired sample t-test was
used to analyse signiﬁcant diﬀerences of arterial pressure
and systemic vascular resistance index (SVRI) related to the
periods of measurement.4 The Scientiﬁc World Journal
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Figure 3: Correlation and Bland-Altman analysis of percentage changes in cardiac index measured by transpulmonary thermodilution
(ΔCITPTD) and cardiac index measured by uncalibrated semi-invasive pulse contour analysis (ΔCIWave) before and after cardiopulmonary
bypass (CPB).
3. Results
Data of all 50 patients, 37 males and 13 females, were
included into ﬁnal analysis. Age ranged between 40 and 85
years,withameanageof 63±5 andameanbodymassindex
of 26.8 ± 3.5kg·m−2. Mean left ventricular ejection fraction
was 0.61 ± 0.07%. A total of 468 data pairs (T1: 245, T2:
223) were obtained during the study period. Haemodynamic
variables are shown in Table 1.
There was a signiﬁcant correlation between CIWave and
CITPTD before (T1) and after (T2) cardiopulmonary bypass
(Figure 2). Correlations, bias, LOAs, and percentage errors
for each time period (T1-T2) are summarized in Table 2.
PLR manoeuvre before CPB (PLR 1) was performed in
47/50 patients and in 42/50 patients after CPB (PLR 2),
respectively. Patients who increased their SVITPTD > 15%
during PLR were deﬁned as responders. We observed 24
responders during PLR 1 (51%) and 23 responders during
PLR2(55%),respectively.Therewasasigniﬁcantcorrelation
between CIWave and CITPTD (r2 = 0.76, P<0.0001) at PLR
1. Correlations and Bland Altman analysis with bias, LOAs,
and percentage errors for PLR before (PLR 1) and after (PLR
2) CPB are presented in Table 2.
The percentage changes for ΔCIWave versus ΔCITPTD are
presented in Figure 3. Bland-Altman analysis showed a sig-
niﬁcant correlation for ΔCIWave versus ΔCITPTD in T1, with
LOAs from −34%to+26%.AfterCPB(T2),correlationcoef-
ﬁcients of changes in ΔCIWave versus ΔCITPTD again were sta-
tistically signiﬁcant, with LOAs ranging from −23 to +25%
(Figure 3). There was a signiﬁcant relationship between
CIWave a n dS V R Ib e f o r e( C I Wave: r2 = 0.27, P<0.0001) and
after (CIWave: r2 = 0.12, P<0.0001) CPB. No signiﬁcant
correlation between MAP and CIWave was observed before
(CIWave: r2 = 0.003, P = 0.42) and after (CIWave: r2 <
0.006, P = 0.25) CPB. Unpaired t-test showed a signiﬁcant
diﬀerence between SVRI before and after CPB (P<0.05).The Scientiﬁc World Journal 5
Table 2: Bland-Altman analysis showing 95% limits of agreement, conﬁdence interval, and percentage error before (T1) and after (T2)
cardiopulmonary bypass and during passive leg raising before (PLR 1) and after (PLR 2) bypass.
T1 T2 PLR 1 PLR 2
ndata/npatient n = 245/n = 50 n = 223/n = 50 n = 132/n = 47 n = 123/n = 42
CIWave CIWave CIWave CIWave
Mean (L/min/m2) 2.38 2.78 2.26 2.76
Bias (L/min/m2) 0.01 0.007 0.05 0.03
SD of bias (L/min/m2) 0.37 0.35 0.34 0.34
CI of LOA (L/min/m2) 0.17 0.16 0.10 0.11
95% limits of agreement (L/min/m2) −0.71 to +0.73 −0.69 to +0.68 −0.63 to +0.72 −0.69 to +0.63
Percentage error (%) 31 25 30 25
CIWave: cardiac index by semi-invasive pulse contour analysis; CITPTD: cardiac index by transpulmonary thermodilution; CI of LOA: conﬁdence interval of
the limits of agreement; PLR: passive leg raising.
4. Discussion
Main ﬁndings of the present study are that the semi-invasive
monitoring device was able to reliably measure CI compared
with transpulmonary thermodilution before and after CPB.
There was a weak but signiﬁcant correlation between semi-
invasive CI by arterial waveform analysis and systemic
vascular resistance index. The semi-invasive monitoring
system was able to track haemodynamic changes and trends
before and after CPB.
The semi-invasive FloTrac/Vigileo-system was developed
to continuously determine CI and stroke volume by arterial
waveform analysis without the need for calibration. As
described elsewhere [11] ,t h i ss y s t e mi sb a s e do nas p e c i a l
software algorithm which calculates CI continuously by
analysis of the arterial blood pressure tracing. Before starting
the system, patient speciﬁc data like age, gender, and body
surface area are required. With respect to the three major
vascular properties: impedance, compliance, and resistance,
determination of cardiac output from arterial waveform
analysisisalsoinﬂuencedbytheinverserelationshipbetween
aortic diameter and pressure [16, 17]. This relationship is
reﬂected in the FloTrac/Vigileo-algorithm by using several
variables like demographic data, mean arterial pressure, and
shape of the arterial waveform to calculate an essential
part of the algorithm: a special equitation named chi (χ).
With respect to rapid changes in vascular tone, the software
version investigated in the present study is able to recalculate
χ every 60 seconds.
Monitoring of haemodynamic variables is mostly related
to invasive procedures, sometimes time-consuming, diﬃcult
to establish and associated with method-related complica-
tions and limitations, respectively [4]. Therefore, a semi-
invasive, quick available, and easy to install method for
continuous estimation of haemodynamic variables may be
advantageousfortheclinicianinthedecisionmakingprocess
of patients’ therapy. Furthermore, besides determination of
absolute values of CI, accurate tracking of haemodynamic
trends could also be extremely valuable while performing
goal-directed therapy. However, suﬃcient accuracy of a
monitoring system is a prerequisite before use in daily
clinical routine. To date, several studies investigated the
semi-invasive monitoring device in varying clinical con-
ditions exhibiting equivocal results [12, 14]. We studied
the “third-generation” software in patients undergoing
elective coronary artery surgery and during a passive leg
raising manoeuvre both before and after cardiopulmonary
bypass.
Applying the criteria as recommended by Critchley
and colleagues [18], we regarded the semi-invasive device
as interchangeable with the reference technique if the
percentage error did not exceed 30%. Before bypass, the
semi-invasive device narrowly missed the strict requirements
as recommended by these authors. These limits, however,
have been criticized extensively by recent literature due to
lack of determination of precision and nonconsideration of
haemodynamic trends [19]. In this context, recent literature
demonstrated less accuracy of CI by arterial waveform
analysis in presence of low vascular resistance [12, 13, 20].
Accordingly, we observed a weak correlation between CI
measured by semi-invasive arterial waveform analysis and
systemic vascular resistance index both before and after
cardiopulmonary bypass. It must be noted, however, that
this observation is based on only few data points from
a small number of patients. Interestingly, we observed
interchangeable results for CI generated by semi-invasive
monitoring device and transpulmonary thermodilution
especially after cardiopulmonary bypass; a study period
typically exhibiting lower values of systemic vascular resis-
tance index. An explanation of these conﬂicting results may
be that in one of the studies cited above patients with
septic shock were enrolled, certainly presenting diﬀerent
systemicvascularresistanceindices comparedtoourpatients
after cardiopulmonary bypass [12]. Furthermore, from a
clinical point of view, CI will be higher in presence
of lower systemic vascular resistance. These ﬁndings will
explain the relationship found in our study, especially since
we obtained interchangeability between arterial waveform
analysis and transpulmonary thermodilution. With respect
to other variables inﬂuencing vascular tone, several studies6 The Scientiﬁc World Journal
demonstrated failure of arterial waveform analysis in pres-
ence of vasoactive agents or high mean arterial pressure
[21–23]. Interestingly, we did not observe a relationship
between CI by semi-invasive arterial waveform analysis
and mean arterial pressure. To investigate the ability of
the semi-invasive device for tracking rapid changes in CI
even in presence of lower systemic vascular resistance, a
passive leg raising maneouvre was performed both before
and after cardiopulmonary bypass. We obtained a signiﬁcant
correlation between CI by arterial waveform analysis and
CI by transpulmonary thermodilution during the passive
leg raising maneouvres. During the ﬁrst manoeuvre, the
semi-invasive monitoring system failed by a narrow margin
to achieve interchangeability with the reference technique,
but after cardiopulmonary bypass accuracy was suﬃcient.
However, beside determination of absolute values of CI, a
monitoring system should be able to track haemodynamic
trends to reﬂect therapeutic interventions. Therefore, we
calculated trends in CI for both monitoring systems and
excluded changes of CI obtained by transpulmonary ther-
modilution <15% from further analysis as recommended
by recent literature [15]. The semi-invasive device showed a
good ability for following trends before and after cardiopul-
monary bypass.
Some limitations of our study should be noted. We
investigated patients with preserved left ventricular function
undergoingelectivecoronaryarterysurgerywithoutongoing
pharmacologic support, and we excluded patients with
haemodynamic instability or in shock. Therefore, our results
cannot be directly transferred to patients with impaired left
ventricular function or inotropic and vasoactive support.
With respect to clinical relevance, several studies could
demonstrate that an individual tailored therapy was associ-
ated with reduced perioperative morbidity. Determination
of cardiac index continuously is an important target while
performing goal-directed therapy.
In conclusion, the present study could demonstrate
reliable measurement of cardiac index and haemodynamic
trendsbysemi-invasivearterialwaveformanalysisinpatients
undergoing elective coronary surgery and with preserved left
ventricular function. Therefore, our results support the use
of less invasive haemodynamic monitoring systems.
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